Tuttle Capital Management, LLC Merck & Co., Inc. Transaction History

Tuttle Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$71.77 - $79.65 $394,017 - $437,278	-5,490 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $401,758 - $455,395	5,490 New	5,490 $455,000
Q1 2020 Apr 09, 2020	SELL	$63.36 - $87.82 $531,463 - $736,634	-8,388 Closed	0 $0
Q4 2019 Jan 13, 2020	BUY	$77.58 - $87.54 $429,172 - $484,271	5,532 Added 193.7%	8,388 $763,000
Q3 2019 Oct 18, 2019	SELL	$76.08 - $82.93 $1.12 Million - $1.22 Million	-14,700 Reduced 83.73%	2,856 $247,000
Q2 2019 Jul 29, 2019	BUY	$69.84 - $81.59 $385,446 - $450,295	5,519 Added 45.85%	17,556 $1.47 Million
Q1 2019 May 10, 2019	BUY	$69.58 - $79.36 $193,014 - $220,144	2,774 Added 29.95%	12,037 $1 Million
Q4 2018 Jan 31, 2019	SELL	$65.24 - $75.71 $804,865 - $934,034	-12,337 Reduced 57.12%	9,263 $708,000
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $1.25 Million - $1.47 Million	21,600 New	21,600 $1.53 Million
Q3 2017 Nov 15, 2017	SELL	$58.67 - $63.13 $744,052 - $800,614	-12,682 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	12,682	12,682 $812,000

3,859

1.89B

15.6M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $219B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.